2L breast has a 2 X 2 cm. hard, non-tender, & movable mass with irregular margins underneath the nippleFibroadenomaFibroadenomas are the second most common solid tumor after breast cancer and the most common benign tumor in womencomposed of stromal and epithelial elements (Benign fibroepithelial neoplasm)commonly seen in young women (20-30 yr)Presents as a massUsually 2-3 cm in size; well-definedSingle in 80%Related to estrogenNot premalignantThe prevalence of fibroadenomas is approximately 8-10% in women older than 40 years. oval, freely mobile, rubbery masses that may be nonpalpable or palpable.size varies from smaller than 1 cm in diameter to as large as 15 cm in diameter in the giant forms.The typical case is the presence of a painless, firm, solitary, mobile, slowly growing lump in the breast of a woman of childbearing years.
3L breast has a 2 X 2 cm. hard, non-tender, & movable mass with irregular margins underneath the nippleFibrocystic ChangeResult of prolonged cyclic stimulation of repeated menstrual cycle35-50 (premenopausal)Presentation is tendernessPain with multiple cystic lesions/single dominant massNot premalignant except those with atypical hyperplasia
4Phylloides Tumor Previously called Cystosarcoma Phylloides L breast has a 2 X 2 cm. hard, non-tender, & movable mass with irregular margins underneath the nipplePhylloides TumorPreviously called Cystosarcoma Phylloidespredominantly benign tumorinvasive- malignantMesenchymal and epithelial componentsRapid growthRarely metastasizes to the axillary lymph nodesPhyllodes tumor is the most commonly occurring nonepithelial neoplasm of the breast, although it represents only about 1% of tumors in the breastIt has a smooth, sharply demarcated texture and typically is freely movable.It is a relatively large tumor, with an average size of 5 cm. However, lesions of more than 30 cm have been reported.can occur in people of any age; however, the median age is the fifth decade of life.
5L breast has a 2 X 2 cm. hard, non-tender, & movable mass with irregular margins underneath the nipplePhylloides TumorPatients typically present with a firm, mobile, well-circumscribed, nontender breast mass.A small mass may rapidly increase in size in the few weeks before the patient seeks medical attention.Tumors rarely involve the nipple-areola complex or ulcerate to the skin.Tends to involve the left breast more commonly than the right one.Overlying skin may display a shiny appearance and be translucent enough to reveal underlying breast veins.
6L breast has a 2 X 2 cm. hard, non-tender, & movable mass with irregular margins underneath the nippleBreast Carcinoma2nd leading site for both sexes combined; 1st among womenIncidence starts rising steeply at age 3014,043 new cases in 2005 among women3rd leading cause of cancer deaths (6,357 breast cancer deaths)Median survival among females is 60 months.Clustered microcalcifications – more common here in the Philippines
7L breast has a 2 X 2 cm. hard, non-tender, & movable mass with irregular margins underneath the nippleBreast CarcinomaHard, solitary, non-tender mass with irregular margins40—60 y/o40-50% are located in the upper outer quadrantSince this area contains greater breast volume, including the axillary tail of Spence80% of the time, there are also lesions in the other quadrantsMost common cause of this discharge is breast CABloody nipple dischargeSkin retractionInvolvement of the ligament of Cooper)Peau d’ orange
9MammographyExaminations of an indeterminate mass that presents as a solitary lesion suspicious of CA10% to 50% of cancers detected mammographically are not palpable, 10% to 20% of palpable tumors not detectable mammographicallyAlthough sensitive, not specific25% of non-palpable lesions detected are found to be malignant at biopsySine qua non (hallmark): Spiculated density with ill-defined margins (If seen in mammography, consider as a malignancy until proven otherwise)Features that are suggestive but not diagnostic of cancer includes:Clustered microcalcifications – more common here in the PhilippinesAsymmetric densityDuctal asymmetryDistortion of skin, nipple & normal breast architecture
10Fine Needle Aspiration Biopsy definitive diagnosisdetermination of histopathology
11Role of the following? 1. FNAB 2. Mammography 3. Chest x-ray 4. Ultrasound5. CT scan6. Bone scan
12FNABFine needle aspiration is the easiest and fastest method of obtaining a breast biopsy, and is very effective for women who have fluid filled cysts.However, the pathological evaluation can be incomplete because the tissue sample is very small. When used alone, about 10% of breast cancers may be missed.
13MammographyMost cost-effective approach for breast cancer screening, however, the sensitivity (67.8%) and specificity (75%) are not ideal.An X-ray technique that looks for changes in the breast. These appear as changes in the shape of the breast or calcifications.demonstrated to be an effective tool for the prevention of advanced breast cancer in women at average riskMammography often reveals a lesion before it is palpable by clinical breast examination and, on average, 1-2 years before noted by breast self-examination. Two-view mammography (ie, craniocaudal and oblique) is the imaging method of choice for breast screening
14MammographyInvestigation of choice for detecting and classifying microcalcification.Benign microcalcification is characterized by diffuse scattering and crescentic "tea-cupping." Malignant microcalcification is characterized by isolated clusters, punctate of varying sizes, and a branching or linear pattern.Mammography is also efficient for helping detect larger patterns of calcification, such as the outlining of calcified arterioles or the coarse patchy calcification of long-standing fibroadenomata.
15Chest X-rayBefore treatment begins, a chest x-ray may be done to rule out metastasis of breast cancer the lungsMay be used to assess the heart and lungs before receiving general anesthesia or chemotherapy.During treatment for breast cancer, chest x-rays may be used in the following situations:If a person has advanced breast cancer that has spread to the lungs, a chest x-ray is used to check on how the disease is responding to treatment.For people who develop a fever during chemotherapy, chest x-rays are used to check for the presence of pneumonia.If a person experiences new shortness of breath in the first few months after radiation therapy, with or without a cough, her doctor may order a chest x-ray to see if the radiation caused any inflammation of the lungs.
16Ultrasound not used on its own as a screening test for breast cancer used to complement other screening tests.If an abnormality is seen on mammography or felt by physical exam, ultrasound is the best way to find out if the abnormality is solid (such as a benign fibroadenoma or cancer) or fluid-filled (such as a benign cyst).cannot determine whether a solid lump is cancerous, nor can it detect calcifications.guide biopsy needles precisely to suspicious areas in the breast.
17UltrasoundUltrasonographic features of malignancy include the following:Poorly defined bordersHeterogeneous internal echoesDisruption of the tissue layersIrregular shadowingSuperficial echo enhancementDepth greater than heightHigh vascular density and flow rates on Doppler imagesFeatures of benign lesions include the following:Cyst - Absence of internal echoes, marked deep enhancementFibroadenoma - Well-defined borders, well-defined internal echoes, and displacement of tissue planesLymph node - Well-defined peripheral blood flow on Doppler images
18CT ScanWith contrast, CT scans can help specify lesions with high vascularity. CT scan is also useful for helping detect lung and brain metastases and high axillary and intrathoracic lymphadenopathy.Right now, CT scans are not used routinely to evaluate the breastAssess whether or not the cancer has moved into the chest wall. This helps determine whether or not the cancer can be removed with mastectomy.Examine other parts of the body where breast cancer can spread, such as the lymph nodes, lungs, liver, brain, and/or spineGenerally, CT scans wouldn’t be needed for early-stage breast cancer.After treatment, CT scans may be used if there is reason to think the breast cancer has spread or recurred outside the breastMay also be used to guide biopsy
19Bone ScanAlso called bone scintigraphy, is an imaging test used to determine whether breast cancer has traveled to the bonesa small quantity of radioactive dye is injected into a vein, and a special X-ray is then taken to see if the cancer has gone to bone.Breast cancer has a predilection to go to bone, where it may lie dormant for many years. A "baseline" scan is obtained for any invasive cancer, to make later scans easier to compare and interpret.during and after treatment, if patient experiences persistent bone and joint pain, or if a blood test suggests the possibility that the breast cancer has traveled to the bonesIf "something" is seen on a bone scan, it may or may not be cancer. Old fractures, inflammation, or infections can make bone scans "light up" in those areas.